{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T12:02:54Z","timestamp":1771761774271,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,22]]},"DOI":"10.7759\/cureus.104055","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T11:34:51Z","timestamp":1771760091000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of the Granulocyte Colony-Stimulating Factor in Sepsis-Associated Immunosuppression: An Open-Label Randomized Controlled Trial"],"prefix":"10.7759","author":[{"given":"K Keerthi","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil Kumar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Kumar","family":"Saroj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandradeep","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tej Bali","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh  M","family":"Palandurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd KE","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al.. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020, 395:200-11. 10.1016\/S0140-6736(19)32989-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000001052","article-title":"Pathophysiology of pediatric multiple organ dysfunction syndrome","volume":"18","author":"Carcillo JA","year":"2017","unstructured":"Carcillo JA, Podd B, Aneja R, et al.. Pathophysiology of pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med. 2017, 18:S32-45. 10.1097\/PCC.0000000000001052","journal-title":"Pediatr Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure","volume":"20","author":"Carcillo JA","year":"2019","unstructured":"Carcillo JA, Berg RA, Wessel D, et al.. A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure. Pediatr Crit Care Med. 2019, 20:1137-46. 10.1097\/PCC.0000000000002105","journal-title":"Pediatr Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000001122","article-title":"Three hypothetical inflammation pathobiology phenotypes and pediatric sepsis-induced multiple organ failure outcome","volume":"18","author":"Carcillo JA","year":"2017","unstructured":"Carcillo JA, Halstead ES, Hall MW, et al.. Three hypothetical inflammation pathobiology phenotypes and pediatric sepsis-induced multiple organ failure outcome. Pediatr Crit Care Med. 2017, 18:513-23. 10.1097\/PCC.0000000000001122","journal-title":"Pediatr Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome","volume":"37","author":"Hall MW","year":"2011","unstructured":"Hall MW, Knatz NL, Vetterly C, et al.. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011, 37:525-32. 10.1007\/s00134-010-2088-x","journal-title":"Intensive Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-025-05527-5","article-title":"Lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-\u0251) levels and health care associated infection (HAI) in children with multi-organ dysfunction syndrome (MODS)","volume":"92","author":"Manwatkar S","year":"2025","unstructured":"Manwatkar S, Saroj AK, Kumar S, et al.. Lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-\u0251) levels and health care associated infection (HAI) in children with multi-organ dysfunction syndrome (MODS). Indian J Pediatr. 2025, 92:632-4. 10.1007\/s12098-025-05527-5","journal-title":"Indian J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/cc10031","article-title":"Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis","volume":"15","author":"Bo L","year":"2011","unstructured":"Bo L, Wang F, Zhu J, et al.. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit Care. 2011, 15:R58. 10.1186\/cc10031","journal-title":"Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein B","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005, 6:2-8. 10.1097\/01.PCC.0000149131.72248.E6","journal-title":"Pediatr Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan TC","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008, 36:309-32. 10.1016\/j.ajic.2008.03.002","journal-title":"Am J Infect Control"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-018-2662-8","article-title":"Ventilator associated pneumonia in pediatric intensive care unit: incidence, risk factors and etiological agents","volume":"85","author":"Vijay G","year":"2018","unstructured":"Vijay G, Mandal A, Sankar J, et al.. Ventilator associated pneumonia in pediatric intensive care unit: incidence, risk factors and etiological agents. Indian J Pediatr. 2018, 85:861-6. 10.1007\/s12098-018-2662-8","journal-title":"Indian J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154330","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial","volume":"78","author":"Vacheron CH","year":"2023","unstructured":"Vacheron CH, Lepape A, Venet F, et al.. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial. J Crit Care. 2023, 78:154330. 10.1016\/j.jcrc.2023.154330","journal-title":"J Crit Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010096","article-title":"Concomitant assessment of monocyte HLA-DR expression and ex vivo TNF-\u03b1 release as markers of adverse outcome after various injuries-insights from the REALISM study","volume":"11","author":"Bidar F","year":"2021","unstructured":"Bidar F, Bodinier M, Venet F, et al.. Concomitant assessment of monocyte HLA-DR expression and ex vivo TNF-\u03b1 release as markers of adverse outcome after various injuries-insights from the REALISM study. J Clin Med. 2021, 11:10.3390\/jcm11010096","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.2021178","article-title":"Immunomodulator use in paediatric severe sepsis and septic shock","volume":"50","author":"Lee AO","year":"2021","unstructured":"Lee AO, Chua AH, Sultana R, et al.. Immunomodulator use in paediatric severe sepsis and septic shock. Ann Acad Med Singap. 2021, 50:765-72. 10.47102\/annals-acadmedsg.2021178","journal-title":"Ann Acad Med Singap"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000048629.32625.5D","article-title":"Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis","volume":"31","author":"Root RK","year":"2003","unstructured":"Root RK, Lodato RF, Patrick W, et al.. Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med. 2003, 31:367-73. 10.1097\/01.CCM.0000048629.32625.5D","journal-title":"Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/2249-4847.105993","article-title":"Granulocyte colony-stimulating factor for preterms with sepsis and neutropenia: a randomized controlled trial","volume":"1","author":"Chaudhuri J","year":"2012","unstructured":"Chaudhuri J, Mitra S, Mukhopadhyay D, et al.. Granulocyte colony-stimulating factor for preterms with sepsis and neutropenia: a randomized controlled trial. J Clin Neonatol. 2012, 1:202-6. 10.4103\/2249-4847.105993","journal-title":"J Clin Neonatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmr012","article-title":"Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial","volume":"58","author":"Gathwala G","year":"2012","unstructured":"Gathwala G, Walia M, Bala H, Singh S. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial. J Trop Pediatr. 2012, 58:12-8. 10.1093\/tropej\/fmr012","journal-title":"J Trop Pediatr"},{"key":"ref17","article-title":"Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia","volume":"21","author":"Khan TH","year":"2012","unstructured":"Khan TH, Shahidullah M, Mannan MA, Nahar N. Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia. Mym Med Jr. 2012, 21:469-74.","journal-title":"Mym Med Jr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003066","article-title":"G-CSF and GM-CSF for treating or preventing neonatal infections","volume":"2003","author":"Carr R","year":"2003","unstructured":"Carr R, Modi N, Dor\u00e9 C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev. 2003, 2003:CD003066. 10.1002\/14651858.CD003066","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel C","year":"2009","unstructured":"Meisel C, Schefold JC, Pschowski R, et al.. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009, 180:640-8. 10.1164\/rccm.200903-0363OC","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415308-efficacy-of-the-granulocyte-colony-stimulating-factor-in-sepsis-associated-immunosuppression-an-open-label-randomized-controlled-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T11:34:52Z","timestamp":1771760092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415308-efficacy-of-the-granulocyte-colony-stimulating-factor-in-sepsis-associated-immunosuppression-an-open-label-randomized-controlled-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.104055","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,22]]}}}